11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 4, 2006, Pages 453-459

  Rubello, Domenico ^a   Fanti, Stefano ^b   Nanni, Cristina ^b   Farsad, Mohsen ^b   Castellucci, Paolo ^b   Boschi, Stefano ^b   Franchi, Roberto ^b   Mariani, Giuliano ^c   Fig, Lorraine M ^d   Gross, Milton D ^d  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

11C methionine PET CT; 99mTc sestamibi; Haemodialysis; Hyperparathyroidism; Neck ultrasound; Renal failure

Indexed keywords

CALCIUM; METHIONINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M; TRACER; CARBON 11 METHIONINE; CARBON-11 METHIONINE; DIAGNOSTIC AGENT; METHIONINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; IMAGE SUBTRACTION; KIDNEY FAILURE; MALE; NECK; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; SCINTIGRAPHY; SEX RATIO; TREATMENT DURATION; ULTRASOUND; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; IMAGE ENHANCEMENT; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RENAL REPLACEMENT THERAPY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; HYPERPARATHYROIDISM; IMAGE ENHANCEMENT; KIDNEY FAILURE, CHRONIC; MALE; METHIONINE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645858290     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-0008-z     Document Type: Article

References (29)

1. Potchen EJ, Wilson RE, Dealy JB Jr. External parathyroid scanning with Se75 selenomethionine. Ann Surg 1965;162:492-504.
2. Sack H, Petry R, Duwell HJ. Darstellung eines Nebenschild-drusenadenoms mit Selen-methionin und der Szintillationskamera. Dtsch Med Wochenschr 1965;90:2353-4.
3. 75Se-methionin. Med Klin 1967;62:672-4.
4. 75Se-selenomethionine dans la mise en evidence preoperatoire de tumeurs parathyroidiennes. Revue Medicale de Liege (Suppl) 1968;1:225.
5. Conte N, Ziliotto D, Scandellari C. Localizzazione scintigrafica delle neoplasie paratiroidee con seleniometionina-Se-75. Acta Isot (Padova) 1965;5:337-45.
6. 75Se-selenomethionine and glucagon stimulation. J Nucl Med 1971;12:751-3.
7. Winzelberg GG, Hydovitz JD. Radionuclide imaging of parathyroid tumors: historical perspectives and newer techniques. Semin Nucl Med 1985;15:161-70.
8. O'Doherty MJ, Kettle AG. Parathyroid imaging: preoperative localization. Nucl Med Commun 2003;24:125-31.
9. Sekiyama K, Akaakura K, Mikami K, Mizoguchi K-I, Tobe T, Nakano K, et al. Usefulness of diagnostic imaging in primary hyperparathyroidism. Int J Urol 2003;10:7-11.
10. Clark PB, Case D, Watson NE, Perrier ND, Morton K. Enhanced scintigraphic protocol required for optimal preoperative localization before targeted minimally invasive parathyroidectomy. Clin Nucl Med 2003;28:955-60.
11. 11C]methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur J Endocrinol 1998;139:195-7.
12. Sundin A, Johansson C, Hellman P, Bergstrom M, Ahlstrom H, Jacobson GB, et al. PET and parathyroid L-[carbon-11] methionine accumulation in hyperparathyroidism. J Nucl Med 1996;37:1766-70.
13. 11C-methionine in hyperparathyroidism. Surgery 1994;116:974-81.
14. 11C-methionine PET. Eur J Nucl Med Mol Imaging 2004;31:1405-12.
15. 99mTc-sestamibi protocol: multiinstitutional experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS). J Nucl Med 2005;46:220-6.
16. 11C methylation on C18 Sep-Pak. J Labelled Cpd Radiopharm 1999;42:715-24.
17. Rubello D, Pelizzo MR, Gross MD, Fig LM, Shapiro B, Mariani G. Controversies on minimally invasive procedures for radio-guided surgery of parathyroid tumours. Minerva Endocrinol 2004;29:189-93.
18. 99mTc-sestamibi and minimally invasive radioguided surgery for primary hyperparathyroidism. J Nucl Med 2005;46:198-99.
19. Gotthardt M, Lohmann B, Behr TM, Bauhofer A, Franzius C, Schipper ML, et al. Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg 2004;28:100-7.
20. Ryan JA, Faye TL. Maximizing outcomes while minimizing exploration in hyperparathyroidism using localization tests. Arch Surg 2004;139:838-43
21. Biertho L, Kim C, Wu H-S, Unger P, Inabnet WB. Relationship between sestamibi uptake, parathyroid hormone assay, and nuclear morphology in primary hyperparathyroidism. J Am Coll Surg 2004;199:229-33.
22. Kakuta T, Suzuki Y, Tadaki F, Tanaka R, Sakai H, Kurokawa K, et al. Long-term prognosis of parathyroid function for chronic dialysis patients after minimally invasive radioguided parathyroidectomy (MIRP). Nephrol Dial Transplant 2003;18 (Suppl 3):iii71-75.
23. 99mTc-sestamibi scintigraphy in chronic hemodialysis patients: correlation with biochemical markers of parathyroid function. Nucl Med Commun 2003;24:85-90.
24. Pons F, Torregrosa JV, Vidal-Sicart S. Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism. Eur J Nucl Med 1997;24:1494-8.
25. Newmann DR, Esselstyn Jr. CB, MacIntyre WJ, Chen EQ, Go RT, Licata AA. Regional body FDG-PET in post-operative recurrent hyperparathyroidism. J Comput Assist Tomogr 1997;21:25-8.
26. Pacak K, Eisenhofer G, Goldstein DS. Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 2004;25:568-80.
27. 11C-methionine position emission tomography. Nucl Med Commun 2005;26:133-6.
28. Sfakianakis GN, Irvin GL, Foss J, Foss J, Mallin W, Georgiou M, et al. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med 1996;37:798-804.
29. Moka D, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Technetium 99m-MIBI-SPECT: a high sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000;128:29-35.